Clinical trial
SMS: Substrate Modification Study in Patients Getting an Implantable…
NCT00170287 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00170287 |
|---|---|
| Title | SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD) |
| Official title | Substrate Modification Study in Patients Getting an ICD |
| Acronym | SMS |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tachycardia, Ventricular |
| Intervention type | Device, Procedure |
| Interventions | ICD Ablation plus VT-ablation, ICD Therapy |
| Enrollment | 116 |
| Start date | May 1, 2002 |
| Primary completion | Apr 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 3, 2025 |
| Countries | Denmark, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: